Literature DB >> 10708272

Use of BPRS-A percent change scores to identify significant clinical improvement: accuracy of treatment response classification in acute psychiatric inpatients.

D Lachar1, S E Bailley, H M Rhoades, R V Varner.   

Abstract

Use of Brief Psychiatric Rating Scale [Overall J.E., Gorham D.R., 1988. The Brief Psychiatric Rating Scale (BPRS): recent developments in ascertainment and scaling. Psychopharmacology Bulletin 24, 97-99] percent change scores (PCSs) to measure treatment effects may be problematic because two different item-weighting systems (0-6 and 1-7) have been employed to represent the seven rating options and PCSs have demonstrated sensitivity to the item-weighting system used. This study compared the ability of a range of BPRS total scale PCS categories generated by both item-weighting procedures to predict estimates of clinical improvement in a large (N = 1415) heterogeneous acute sample of adult psychiatric inpatients. Results revealed significant differences between the two scaling systems in the proportion of patients classified into categories of PCS symptom improvement. Additional analysis suggested different optimal predictive PCS classifications for each item-weighting system: > 19% for 1-7 and > 39% for 0-6. Guidelines for BPRS publications are presented to facilitate study interpretation and replication. In light of their demonstrated limitations, it is suggested that the use of BPRS PCSs to measure treatment effects be reconsidered.

Entities:  

Mesh:

Year:  1999        PMID: 10708272     DOI: 10.1016/s0165-1781(99)00114-6

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  12 in total

1.  Who receives antidepressants and what impact do they have? An acute-care study.

Authors:  Patricia M Averill; Adel A Wassef
Journal:  Psychiatr Q       Date:  2006

2.  Outcome and length of stay in psychiatric hospitalization, the experience of the University Clinic of Turin.

Authors:  Paola Rocca; C Mingrone; T Mongini; C Montemagni; L Pulvirenti; G Rocca; F Bogetto
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2009-07-08       Impact factor: 4.328

3.  Increased Belief Instability in Psychotic Disorders Predicts Treatment Response to Metacognitive Training.

Authors:  D J Hauke; V Roth; P Karvelis; R A Adams; S Moritz; S Borgwardt; A O Diaconescu; C Andreou
Journal:  Schizophr Bull       Date:  2022-06-21       Impact factor: 7.348

4.  Ratings of early major depressive disorder symptom change during a brief psychiatric hospitalization.

Authors:  Jeremy W Pettit; Patricia M Averill; Adel A Wassef; Nelson P Gruber; Laurie Schneider
Journal:  Psychiatr Q       Date:  2005

5.  Genetic variants in the BDNF gene and therapeutic response to risperidone in schizophrenia patients: a pharmacogenetic study.

Authors:  Mingqing Xu; Sheng Li; Qinghe Xing; Rui Gao; Guoyin Feng; Zhiguang Lin; David St Clair; Lin He
Journal:  Eur J Hum Genet       Date:  2010-01-20       Impact factor: 4.246

6.  Clinical outcome and length of stay in an Italian Psychiatric Emergency Service.

Authors:  T Frieri; C Montemagni; G Rocca; P Rocca; V Villari
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2012-10-30       Impact factor: 4.328

7.  The Effects of Probiotic and Selenium Co-supplementation on Clinical and Metabolic Scales in Chronic Schizophrenia: a Randomized, Double-blind, Placebo-Controlled Trial.

Authors:  Hamidreza Jamilian; Amir Ghaderi
Journal:  Biol Trace Elem Res       Date:  2021-01-06       Impact factor: 3.738

8.  Development of an instrument to measure patients' attitudes towards involuntary hospitalization.

Authors:  Adel Gabriel
Journal:  World J Psychiatry       Date:  2017-06-22

9.  Clinical and metabolic response to vitamin D plus probiotic in schizophrenia patients.

Authors:  Amir Ghaderi; Hamid Reza Banafshe; Naghmeh Mirhosseini; Mohamad Moradi; Mohammad-Amin Karimi; Fateme Mehrzad; Fereshteh Bahmani; Zatollah Asemi
Journal:  BMC Psychiatry       Date:  2019-02-21       Impact factor: 3.630

10.  Association of dopamine receptor polymorphisms with schizophrenia and antipsychotic response in a South Indian population.

Authors:  Neetha N Vijayan; Sujatha Bhaskaran; Linda V Koshy; Chandrasekhar Natarajan; Lekshmy Srinivas; Chandrasekharan M Nair; Priya M Allencherry; Moinak Banerjee
Journal:  Behav Brain Funct       Date:  2007-07-25       Impact factor: 3.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.